Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical evaluation of 1,2,4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates
Barbara Kaproń, Jarogniew J. Łuszczki, Agata Siwek, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103355-103355
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

1,2,4-Triazoles as Important Antibacterial Agents
Małgorzata Strzelecka, Piotr Świątek
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 224-224
Open Access | Times Cited: 139
An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship
Ojasvi Gupta, Tathagata Pradhan, Gita Chawla
Journal of Molecular Structure (2022) Vol. 1274, pp. 134487-134487
Closed Access | Times Cited: 47
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 36
Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABAA receptor
Shiben Wang, Hui Liu, Xuekun Wang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112672-112672
Closed Access | Times Cited: 51
1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy
Barbara Kaproń, Robert Czarnomysy, Mariusz Wysokiński, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 993-1002
Open Access | Times Cited: 45
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors
Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 5
Closed Access | Times Cited: 35
New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies
Małgorzata Strzelecka, Benita Wiatrak, Paulina Jawień, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106758-106758
Open Access | Times Cited: 11
Synthesis, computational studies and evaluation of benzisoxazole tethered 1,2,4-triazoles as anticancer and antimicrobial agents
Deepika Dwarakanath, K. Ananda, Basappa Basappa, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138070-138070
Open Access | Times Cited: 4
A review on the synthesis and applications of molecules as anticonvulsant drug agent candidates
Oğuz Özbek, Meliha Burcu Gürdere
Medicinal Chemistry Research (2020) Vol. 29, Iss. 9, pp. 1553-1578
Closed Access | Times Cited: 30
Antibacterial Activity of Fluorobenzoylthiosemicarbazides and Their Cyclic Analogues with 1,2,4-Triazole Scaffold
Urszula Kosikowska, Monika Wujec, Nazar Trotsko, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 170-170
Open Access | Times Cited: 30
Synthesis, Antimicrobial Activity, Molecular Docking and DFT Study: Aryl‐Carbamic Acid 1‐Benzyl‐1H‐[1,2,3]Triazol‐4‐ylmethyl Esters
Naveen Naveen, Ram Kumar Tittal, Ghule D. Vikas, et al.
ChemistrySelect (2020) Vol. 5, Iss. 22, pp. 6723-6729
Closed Access | Times Cited: 28
Design, synthesis and pharmacological evaluation of triazolopyrimidines derivatives as novel agonists for benzodiazepine receptor
Mengjiao Li, Lina Hu, Shijia Yi, et al.
Journal of Molecular Structure (2025), pp. 141611-141611
Closed Access
Design and synthesis of new benzimidazole-hybrids as anti-microbial agents: exploring the mechanistic insights as DNA gyrase inhibitors via in silico and in vitro based studies
Anand Maurya, Upendra Kumar Patel, Punit Tiwari, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-20
Closed Access
Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs)
Ayşegül Karaküçük‐İyidoğan, Eyüp Başaran, Gizem Tatar-Yılmaz, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107662-107662
Closed Access | Times Cited: 2
Antioxidant and antibacterial activities of 5-mercapto(substitutedthio)-4-substituted-1,2,4-triazol based on nalidixic acid: A comprehensive study on its synthesis, characterization, and In silico evaluation
Ibrahim Mhaidat, Sojoud Banidomi, Fadel Wedian, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28204-e28204
Open Access | Times Cited: 1
The Inclusion of Tolfenamic Acid into Cyclodextrins Stimulated by Microenvironmental pH Modification as a Way to Increase the Anti-Migraine Effect
Anna Stasiłowicz-Krzemień, Ewa Tykarska, Natalia Rosiak, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 981-992
Open Access | Times Cited: 8
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents
Maria Marinescu
(2023)
Open Access | Times Cited: 3
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking
Mukund Jha, Ozair Alam, Mohd. Javed Naim, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 153, pp. 105494-105494
Closed Access | Times Cited: 7
Design and One-Pot Synthesis of Some New [3,5-Di(4’,5’-diphenyl-2’-substituted)-1H-imidazol-1-yl)]-1H-1,2,4-triazole Derivatives: in silico ADMET and Docking Study, Antibacterial and Antifungal Activities Evaluation
Nadia Hadhoum, Fatima Zohra Hadjadj-Aoul, Smaïn Hocine, et al.
Heterocycles (2021) Vol. 102, Iss. 10, pp. 1949-1949
Open Access | Times Cited: 7
Effect of Chronic Administration of 5-(3-chlorophenyl)-4-Hexyl-2,4 -Dihydro-3H-1,2,4-Triazole-3-Thione (TP-315)—A New Anticonvulsant Drug Candidate—On Living Organisms
Anna Makuch‐Kocka, Marta Andres‐Mach, Mirosław Zagaja, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3358-3358
Open Access | Times Cited: 6
Syntheses and Antioxidant Activity of 1-Isonicotinoyl-4-phenylthiosemicarbazide and Crystal Structures of N-Phenyl-5-(pyridin-4-yl)-1,3,4-oxadiazol-2-amine Hydrochloride and 4-Phenyl-3-(pyridin-4-yl)-1H-1,2,4-triazole-5(4H)-thione derived from 1 Isonicotinoyl-4-phenylthiosemicarbazide
Ndama Faye, Bédié Mbow, Aïssatou Alioune Gaye, et al.
Earthline Journal of Chemical Sciences (2022), pp. 189-208
Open Access | Times Cited: 4
Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives
Kinga Paruch, Barbara Kaproń, Jarogniew J. Łuszczki, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5287-5287
Open Access | Times Cited: 2
Unravelling the potency of triazole analogues for inhibiting α-synuclein fibrillogenesis andin vitrodisaggregation
Mudasir Maqbool, Joshna Gadhavi, Anju Singh, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 7, pp. 1589-1603
Closed Access | Times Cited: 5
Anticonvulsant Effectiveness and Neurotoxicity Profile of 4-butyl-5-[(4-chloro-2-methylphenoxy)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (TPL-16) in Mice
Magdalena Drabik, Mariusz Głuszak, Paula Wróblewska-Łuczka, et al.
Neurochemical Research (2020) Vol. 46, Iss. 2, pp. 396-410
Open Access | Times Cited: 4
A new silver(I) coordination polymer containing bitopic 1,2,4-triazole derivative: Synthesis, structural investigation, and thermal behavior
Sahar Amiri, Mitra Ghassemzadeh, B. Neumüller, et al.
Polyhedron (2021) Vol. 197, pp. 115039-115039
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top